YMAB
Y-mAbs Therapeutics, Inc
Price:  
4.10 
USD
Volume:  
108,610.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

YMAB WACC - Weighted Average Cost of Capital

The WACC of Y-mAbs Therapeutics, Inc (YMAB) is 6.8%.

The Cost of Equity of Y-mAbs Therapeutics, Inc (YMAB) is 9.90%.
The Cost of Debt of Y-mAbs Therapeutics, Inc (YMAB) is 5.00%.

Range Selected
Cost of equity 7.60% - 12.20% 9.90%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.6% - 7.9% 6.8%
WACC

YMAB WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.8 1.32
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.60% 12.20%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.6% 7.9%
Selected WACC 6.8%